Inflammatory Bowel Diseases: Clinical Trials

3,829 trials for Inflammatory Bowel Diseases, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1756 completed, 634 unknown, 519 recruiting, 389 terminated. 957 Not applicable, 668 Phase 2, 460 Phase 3, 356 Phase 1, 269 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable957Completed 389, Unknown 210, Recruiting 149, Terminated 72, Not yet recruiting 55, Active not recruiting 35, Withdrawn 29, Enrolling by invitation 12, Suspended 6
Phase 2668Completed 306, Terminated 135, Recruiting 92, Unknown 54, Withdrawn 33, Active not recruiting 27, Not yet recruiting 16, Enrolling by invitation 4, Suspended 1
Phase 3460Completed 250, Terminated 74, Unknown 46, Recruiting 40, Active not recruiting 27, Withdrawn 16, Not yet recruiting 5, Enrolling by invitation 2
Phase 1356Completed 194, Terminated 47, Recruiting 33, Unknown 33, Not yet recruiting 20, Withdrawn 17, Active not recruiting 8, Enrolling by invitation 3, Suspended 1
Phase 4269Completed 120, Unknown 41, Recruiting 34, Terminated 33, Not yet recruiting 19, Withdrawn 13, Active not recruiting 6, Enrolling by invitation 3
Early Phase 144Unknown 14, Completed 8, Not yet recruiting 7, Recruiting 6, Withdrawn 4, Terminated 3, Active not recruiting 1, Enrolling by invitation 1

Follow Inflammatory Bowel Diseases: new trials by email Literature Review of Inflammatory Bowel Diseases trials Research Report on Inflammatory Bowel Diseases

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Dose Ranging Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Budesonide Rectal Foam in Pediatric Patients Aged 5 to 17 Years With Active, Mild to Moderate Distal Ulcerative Colitis
High dose budesonide rectal foam, Low dose budesonide rectal foam, Matching placebo rectal foam - Ulcerative Colitis
Phase 4Not yet recruitingBausch Health Americas, Inc.1002029-06-012026-10-06
ACT for Veterans With IBD and Mental Health Challenges
Acceptance and Commitment Therapy - Inflammatory Bowel Diseases, Crohn's Disease
Not applicableNot yet recruitingVA Office of Research and Development502028-01-012026-02-09
A Mindfulness-based Stress Reduction Program for IBD
Mindfulness based stress reduction, Active Control - Inflammatory Bowel Disease (Crohn&Amp;#39;s Disease and Ulcerative Colitis)
Not applicableNot yet recruitingNova Scotia Health Authority702027-09-012026-09-08
Digital Mind Body Intervention Among Black and Hispanic Patients Living With Inflammatory Bowel Disease
Digital Mind Body Intervention mobile application - Crohn's Disease, Ulcerative Colitis
Not applicableNot yet recruitingMontefiore Medical Center402027-07-012026-11-16
Adapted Physical Activity for Persistent Fatigue in Patients With Inflammatory Bowel Disease in Remission
Adapted Physical Activity, Usual Care - Inflammatory Bowel Diseases (IBD), Fatigue
Not applicableNot yet recruitingUniversity Hospital, Grenoble1202027-06-012026-09-11
ASAPP Study - Topical 5-ASA as Prophylaxis for Pouchitis in Ulcerative Colitis Patients After Pelvic Pouch Surgery
5-ASA, Placebo - Ulcerative Colitis (UC), Pouchitis
Phase 4Not yet recruitingUniversity Hospital, Linkoeping1102027-04-012026-08-19
LMT503 First-in-human SAD, MAD, and FE Study
LMT503, Placebo - Inflammatory Bowel Disease, Colitis, Ulcerative
Phase 1Not yet recruitingLmito Therapeutics Inc.722027-03-012026-09-01
Efficacy and Safety of TRA16 Administered Orally in Patients With Enteric Hyperoxaluria (EH).
TRA16, Placebo - Enteric Hyperoxaluria
Phase 2Not yet recruitingWuhan Kangfude Urolithiasis Research Institute Co., Ltd.302027-03-012026-10-13
Pilot Trial of Xylitol for C. Difficile De-Colonization in Patients With Inflammatory Bowel Disease
Xylitol - Inflammatory Bowel Disease (IBD), Clostridioides Difficile Infection
Early Phase 1Not yet recruitingBrigham and Women's Hospital692027-03-012026-11-16
Xylitol Use for Decolonization of C. Difficile in Patients With IBD
Xylitol, Placebo - Inflammatory Bowel Diseases, Clostridioides Difficile Infection
Phase 1Not yet recruitingBrigham and Women's Hospital992027-03-012026-11-18
NaviCam Patency Capsule to Verify Gastrointestinal Patency
NaviCam Patency Capsule - Intestinal Stricture, Crohn Disease
Not applicableNot yet recruitingAnX Robotica Corp.252027-02-152026-11-20
Duodenal Mucosa Responses to Endoscopic Food Challenges in Patients With Inflammatory Bowel Disease and Irritable Bowel Syndrome With Self-reported Food Intolerances: A Feasibility Study
Upper diagnostic endoscopy with food challenges and biopsies - Food Intolerance, IBD (Inflammatory Bowel Disease)
Not applicableNot yet recruitingMcMaster University122027-02-012026-11-19
Oral N-acetylglucosamine in Crohn's Disease
N-Acetylglucosamine (GlcNAc) - Crohns Disease
Phase 2Not yet recruitingJohns Hopkins University402027-01-052026-11-05
Tirzepatide for Ileal Pouch-anal Anastomosis (IPAA) and Chronic High Bowel Frequency (I8F-NS-X008)
Tirzepatide, Loperamide, Diphenoxylate/Atropine - Pouch, Ileal, Pouches, Ileoanal
Phase 4RecruitingUniversity of North Carolina, Chapel Hill202027-01-042026-11-18
Biophysical Assessments of Acupuncture Points in Inflammatory Bowel Disease
Inflammatory Bowel Disease (IBD)
Not yet recruitingBrigham and Women's Hospital1002027-01-012026-10-20
Oral Aeromonas sp. MTB Phage Therapy for Pouchitis in Patients With Ulcerative Colitis (UC)
MTB-targeted phage therapy - Pouchitis, UC - Ulcerative Colitis
Early Phase 1Not yet recruitingJinling Hospital, China122027-01-012026-10-22
Safety and Efficacy of a STOPping Strategy Versus Classical Maintenance Dose of JAK Inhibitors in Deep Remission Patients With Ulcerative Colitis
treatment withdrawal - Ulcerative Colitis in Remission
Phase 4Not yet recruitingAssistance Publique Hopitaux De Marseille2242027-01-012026-11-10
Intertriginous/Periorificial Dermatoses in Patients With IBD on Anti-TNFα: Relative Abundance of Staphylococcus Aureus Within the Lesion Microbiota and Clinical Correlation (micSPIDER).
Inflammatory Bowel Diseases, Crohn's Disease
Not yet recruitingCentre Hospitalier Universitaire de Nīmes822027-01-012026-11-13
Prophylactic Phasix™ Mesh for Incisional Hernia Prevention in IBD Surgery: A Prospective Multicenter Study
Phasix Mesh - Inflammatory Bowel Disease (IBD), Chrohn's Disease
Not applicableNot yet recruitingIRCCS Azienda Ospedaliero-Universitaria di Bologna1502026-12-312026-11-18
Safety, Tolerability and PK of ATTO 1091 in Healthy Adult Volunteers and Patients With Ulcerative Colitis
ATTO-1091, Placebo - Ulcerative Colitis (UC)
Phase 1Not yet recruitingAttovia Therapeutics Inc962026-12-142026-09-15

Showing 20 of 3829. Sign in to see all of them.

Narrower conditions

Crohn Disease (1954)  ·  Colitis, Ulcerative (1802)  ·  Arthritis, Rheumatoid (85)  ·  Colitis (77)  ·  Irritable Bowel Syndrome (75)  ·  Colorectal Neoplasms (62)  ·  Arthritis, Psoriatic (56)  ·  Gastrointestinal Diseases (51)  ·  Psoriasis (48)  ·  Spondylitis, Ankylosing (48)  ·  Inflammation (47)  ·  Colonic Neoplasms (44)  ·  Intestinal Diseases (41)  ·  Digestive System Diseases (34)

Broader conditions

Gastroenteritis (3816)  ·  Digestive System Diseases (3795)  ·  Intestinal Diseases (3788)  ·  Gastrointestinal Diseases (3778)  ·  Colonic Diseases (1919)  ·  Colitis (1754)  ·  Pathological Conditions, Signs and Symptoms (416)  ·  Pathologic Processes (229)  ·  Immune System Diseases (172)  ·  Musculoskeletal Diseases (155)  ·  Skin and Connective Tissue Diseases (152)  ·  Neoplasms (143)  ·  Nutritional and Metabolic Diseases (140)  ·  Joint Diseases (137)

Interventions

Infliximab (140)  ·  Adalimumab (107)  ·  Mesalamine (102)  ·  vedolizumab (93)  ·  Fecal Microbiota Transplantation (70)  ·  Ustekinumab (65)  ·  Azathioprine (46)  ·  Blood Specimen Collection (39)  ·  Certolizumab Pegol (35)  ·  Colonoscopy (31)  ·  Cholecalciferol (27)  ·  Endoscopy (27)  ·  golimumab (27)  ·  mirikizumab (27)  ·  risankizumab (26)

Sponsors

Takeda (80)  ·  AbbVie (74)  ·  Assiut University (54)  ·  Pfizer (52)  ·  Janssen Research & Development, LLC (45)  ·  Sixth Affiliated Hospital, Sun Yat-sen University (40)  ·  Mayo Clinic (33)  ·  Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives (30)  ·  Ferring Pharmaceuticals (29)  ·  GlaxoSmithKline (29)  ·  Assistance Publique - Hôpitaux de Paris (28)  ·  Second Affiliated Hospital of Wenzhou Medical University (27)  ·  Central Hospital, Nancy, France (26)  ·  Merck Sharp & Dohme LLC (25)  ·  Bristol-Myers Squibb (24)

Countries

United States (1208)  ·  France (523)  ·  Canada (516)  ·  Germany (423)  ·  United Kingdom (411)  ·  Italy (399)  ·  China (387)  ·  Poland (356)  ·  Belgium (355)  ·  Israel (345)  ·  Netherlands (319)  ·  Spain (316)  ·  Hungary (268)  ·  Czechia (257)  ·  Australia (245)

Top investigators

Arie Levine, MD (10)

Results publications

PMID 40243391, PMID 40357993, PMID 40013523, PMID 29380251, PMID 32445184, PMID 26893500, PMID 35648151, PMID 36124702, PMID 37368103, PMID 29850873, PMID 30476584, PMID 30739254, PMID 31077827, PMID 31599001, PMID 32816215, PMID 33684552, PMID 35792493, PMID 36342120, PMID 36526796, PMID 36931693, PMID 38425446, PMID 39778975, PMID 25996351, PMID 32635680, PMID 32766762, PMID 32870265, PMID 32964215, PMID 33127596, PMID 33324993, PMID 33513294, PMID 34614208, PMID 35380664, PMID 35380740, PMID 36150926, PMID 36208720, PMID 36336750, PMID 37224198, PMID 37402275, PMID 37560161, PMID 38096402, PMID 38310565, PMID 38778549, PMID 41264726, PMID 41763462, PMID 42248437, PMID 16339095, PMID 19596014, PMID 23648372, PMID 25173754, PMID 25857665

NIH funding

2023 (49), 2017 (42), 2016 (30), 2014 (25), 2018 (25), 2015 (22), 2019 (22), 2025 (21), 2008 (9), 2009 (8), 2004 (6), 2005 (4), K12TR004411 (2), K24DK078228 (2), P30CA060553 (2)